Table 3.
Observations based on hematological profile—full Cohort, all regions.
| Observations | Female | Male | Total | p value |
|---|---|---|---|---|
| For confirmed lab values (n = 956) | ||||
| Group A (ferritin ≥30) | 161 (27.5%) | 424 (72.5%) | 585 (61.2%) | <0.001 |
| Ferritin ≥30, Hb above normal limits∗ | 138 | 416 | ||
| Ferritin ≥30, Hb low∗∗ | 23 | 8 | ||
| Group B (low ferritin, normal Hb) | 239 (88.8%) | 30 (11.2%) | 269 (28.1%) | |
| Ferritin ≥15 and <30, Hb above normal limits | 136 | 25 | ||
| Ferritin ≥12 and <15, Hb above normal limits | 30 | 3 | ||
| Ferritin <12, Hb above normal limits | 73 | 2 | ||
| Group C (low ferritin and low Hb) | 96 (94.1%) | 6 (5.9%) | 102 (10.7%) | |
| Ferritin ≥15 and <30, Hb low | 20 | 2 | ||
| Ferritin ≥12 and <15, Hb low | 7 | 0 | ||
| Ferritin <12, Hb low | 69 | 4 | ||
|
| ||||
| Thalassemia | ||||
| Hb-A2 ≤ 3.5% | 450 (98.5%) | 398 (99%) | 848 (98.7%) | |
| Hb-A2 > 3.5% | 7 (1.5%) | 4 (1%) | 11 (1.3%) | |
|
| ||||
| Sickle cell anemia | ||||
| Hb-S ≤ 23% | 2 (8%) | 1 (5.6%) | 3 (7%) | |
| Hb-S > 23% | 23 (92%) | 17 (94.4%) | 40 (93%) | |
Two students were positive for both thalassemia and sickle cell anemia. ,∗Male ≥13, female ≥12;∗∗male < 13, female <12.